Structure

Ethyl (R)-(+)-4-chloro-3-hydroxybutyrate

CAS
90866-33-4
Catalog Number
ACM90866334
Category
Main Products
Molecular Weight
166.60
Molecular Formula
ClCH2CH(OH)CH2CO2C2H5

If you have any other questions or need other size, please get a quote.

  • Product Description
  • Case Study
  • Custom Reviews
  • Custom Q&A
  • Synthetic Use
  • Related Resources

Specification

Synonyms
ethyl (3R)-4-chloro-3-hydroxybutanoate;
IUPAC Name
ethyl(3R)-4-chloro-3-hydroxybutanoate
SMILES
CCOC(=O)CC(CCl)O
InChI Key
ZAJNMXDBJKCCAT-RXMQYKEDSA-N
Boiling Point
93-95ºC (5 mmHg)
Melting Point
93-95ºC
Flash Point
109ºC
Density
1.19
Appearance
colorless to light yellow transparent liquid
Exact Mass
166.04000
Hazard Statements
Xi:Irritant
Packing Group
III
Safety Description
S26-S36

Efficient Biocatalytic Production of Ethyl (R)-4-chloro-3-hydroxybutyrate Using a Novel Carbonyl Reductase

Effect of reaction conditions on the synthesis of ethyl (R)-4-chloro-3-hydroxybutyrate in co-expressing E. coli cells. Chen, Xiang, et al. BMC biotechnology 16.1 (2016): 70.

Ethyl (R)-4-chloro-3-hydroxybutyrate ((R)-CHBE) is a high-value chiral synthon required for the manufacture of several pharmaceuticals, such as L-carnitine and some neuromodulators. The enzymatic asymmetric synthesis is the preferred mode of production, however the previously reported biocatalytic routes for (R)-CHBE have significant limitations, presenting a demand to develop an improved, more robust process.
A novel stereoselective carbonyl reductase (BgADH3) was discovered and utilized for the reduction of prochiral ethyl 4-chloro-3-oxobutanoate (COBE) to (R)-CHBE. BgADH3, which was isolated from Burkholderia gladioli, was shown to have high activity and enantioselectivity for this transformation.
Key Results
· To create an efficient production system, the BgADH3 enzyme was implemented in a whole-cell biocatalyst. Recombinant E. coli cells were engineered to co-express both BgADH3 and a glucose dehydrogenase, creating an integrated system for cofactor (NADPH) regeneration. This design eliminated the need for adding expensive external cofactors.
· The bioconversion was successfully scaled using a substrate fed-batch strategy in an aqueous/octanol biphasic system, which helped manage substrate and product inhibition. This optimized process achieved the complete conversion of 1200 mmol of COBE, producing (R)-CHBE with excellent enantiomeric excess (>99.9%). The process demonstrated high productivity, with a space-time yield of 4.47 mmol/L/h·g DCW-1.

Please kindly note that our products are for research use only.

Alfa Chemistry

For product inquiries, please use our online system or send an email to .

Alfa Chemistry
Shopping basket
Loading...
Loading...
Download PDF documentDownload
* I hereby give my consent that I may receive marketing e-mails with information on existing and new services from this company. I know that I can opt-out from receiving such e-mails at any time or by using the link which will be provided in each marketing e-mail.